Organicell announces FDA approval of IND application for the treatment of SARS due to COVID-19

May 6, 2020 Leave a comment 2,204 Views

Organicell Regenerative Medicine, Inc. a clinical-stage biopharmaceutical company dedicated to the development of regenerative therapies, announced today that the U.S. Food and Drug Administration...

Exosome RNA Exosome RNA Research & Industry News

Tag Archives: IND application

Organicell announces FDA approval of IND application for the treatment of SARS due to COVID-19

‘Golden’ exosomes as delivery vehicles to target tumors and overcome intratumoral barriers

Methods for isolation and quantification of exosomes

UTMB team proves potential for reducing pre-term birth by treating fetus with bioengineered exosomes

Exosomes targeted towards applications in regenerative medicine

Research in extracellular vesicles earns Young Investigator Award

New publication details the characterization of novel scaffold proteins that can enable engineered exosomes with defined therapeutic properties